Financials
- Market Capitalization 1.83 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2071 | ZYME Zymeworks Inc. - Common Stock | 24.80 USD | +0.57% | -5.78% | +6.44% | +39.80% | 1.81 B USD | ||
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.35 USD | +0.30% | -9.70% | +2.45% | -36.67% | 1.78 B USD | ||
| 2094 | ZBIO Zenas BioPharma, Inc. - Common Stock | 28.14 USD | -2.22% | +4.73% | +50.00% | +6.35% | 1.78 B USD | ||
| 2117 | IMCR Immunocore Holdings plc - American Depositary Shares | 33.60 USD | +0.39% | +1.94% | +17.44% | +0.36% | 1.71 B USD |
Frequently asked questions about Precigen, Inc. - Common Stock
What is the Precigen, Inc. - Common Stock stock price today?
The current price of Precigen, Inc. - Common Stock (PGEN) is 5.14. Over the past 24 hours, the stock has changed by +0.39%. Follow the PGEN chart for real-time price dynamics.
What is the stock ticker of Precigen, Inc. - Common Stock?
Precigen, Inc. - Common Stock trades under the ticker PGEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Precigen, Inc. - Common Stock stock going up?
PGEN has changed by -6.72% over the last week, +6.86% over the last month, and +176.34% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Precigen, Inc. - Common Stock net income for the last quarter?
Precigen, Inc. - Common Stock reported net income of -7.93 M for the last quarter. The previous quarter showed -23.5 M, which means net income changed by +66.26%.
How many employees does Precigen, Inc. - Common Stock have?
As of the latest available data, Precigen, Inc. - Common Stock has 47 employees. Workforce size can provide additional context about the company's scale and operations.
What is Precigen, Inc. - Common Stock EBITDA?
Precigen, Inc. - Common Stock EBITDA is -4.89 M, and its EBITDA margin is -21.05%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Precigen, Inc. - Common Stock stock?
You can buy Precigen, Inc. - Common Stock (PGEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Precigen, Inc. - Common Stock stock?
Investing in Precigen, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PGEN chart and related analysis on metatrader.com as part of your research.